Bioventus BVS - 옵션 체인 | ADVFN

다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

Bioventus Inc (BVS)

9.03

-0.06

(-0.66%)

마감 29 3월 5:00AM

9.03

0.005

(0.06%)

시간외 거래: 6:30AM

BVS 실시간 옵션 플로우

콜

행사 가격	매수가	매도가	최근 가격	중간 가격	가격 변동	가격 변동 %	거래량	미결제 약정	최근 거래
2.50	5.90	7.40	0.00	6.65	0.00	0.00 %	0	0	-
5.00	3.50	4.50	6.41	4.00	0.00	0.00 %	0	10	-
7.50	1.50	2.15	2.30	1.825	0.00	0.00 %	0	39	-
10.00	0.15	0.30	0.65	0.225	0.00	0.00 %	0	33	-
12.50	0.15	0.10	0.15	0.125	0.00	0.00 %	0	322	-
15.00	0.30	0.30	0.30	0.30	0.00	0.00 %	0	177	-
17.50	0.29	0.75	0.29	0.52	0.00	0.00 %	0	50	-
20.00	0.45	0.75	0.45	0.60	0.00	0.00 %	0	60	-
22.50	0.90	0.75	0.90	0.825	0.00	0.00 %	0	1	-

개인 투자자를 위한 전문가급 도구.

풋

행사 가격	매수가	매도가	최근 가격	중간 가격	가격 변동	가격 변동 %	거래량	미결제 약정	최근 거래
2.50	0.00	0.75	0.00	0.00	0.00	0.00 %	0	0	-
5.00	0.05	0.05	0.05	0.05	0.00	0.00 %	0	50	-
7.50	0.05	0.20	0.10	0.125	0.00	0.00 %	0	261	-
10.00	0.25	1.35	1.30	0.80	0.35	36.84 %	1	26	29/03/2025
12.50	3.10	4.00	2.75	3.55	0.00	0.00 %	0	0	-
15.00	5.60	6.60	4.60	6.10	0.00	0.00 %	0	0	-
17.50	8.00	9.10	0.00	8.55	0.00	0.00 %	0	0	-
20.00	10.60	11.60	0.00	11.10	0.00	0.00 %	0	0	-
22.50	13.10	13.80	0.00	13.45	0.00	0.00 %	0	0	-

가장 활성
% 상승자
% 패자

기호	가격	볼륨
PRTGPortage Biotech Inc	US$ 9.60 (103.82%)	29.92M
LXRXLexicon Pharmaceuticals Inc	US$ 0.5741 (65.16%)	405.3M
DBVTDBV Technologies SA	US$ 6.12 (56.52%)	21.8M
MYSZMy Size Inc	US$ 1.79 (42.06%)	11.89M
LXEHLixiang Education Holding Company Ltd	US$ 17.70 (32.78%)	217.53k
STSSSharps Technology Inc	US$ 0.0421 (-72.43%)	214.43M
MISTMilestone Pharmaceuticals Inc	US$ 0.88 (-60.89%)	33.47M
XTIAXTI Aerospace Inc	US$ 1.23 (-50.00%)	1.82M
LGMKLogicMark Inc	US$ 0.0258 (-49.41%)	161.36M
ICONIcon Energy Corporation	US$ 0.0516 (-48.40%)	27.6M
LXRXLexicon Pharmaceuticals Inc	US$ 0.5741 (65.16%)	405.3M
DMNDamon Inc	US$ 0.0346 (-22.42%)	313.46M
NVDANVIDIA Corporation	US$ 109.67 (-1.58%)	229.86M
STSSSharps Technology Inc	US$ 0.0421 (-72.43%)	214.38M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 9.845 (-7.30%)	200.2M

Monksdream

Monksdream 5 월 전

Monksdream

Monksdream 5 월 전

BVS anew 52 week high

Monksdream

Monksdream 7 월 전

BVS new 52=high

Monksdream

Monksdream 7 월 전

BVS new 52 week high

Monksdream

Monksdream 9 월 전

tw0122

tw0122 11 월 전

Durolane like it .. older news ..Bioventus Agrees to Nationwide Contract with Aetna™ Medicare Advantage Plans for DUROLANE® for Knee Osteoarthritis

Source: GlobeNewswire Inc.

Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has agreed to a nationwide contract with Aetna™ Medicare Advantage plans. Beginning January 1, 2024, over 3 million Aetna™ Medicare Advantage plan members will have access to DUROLANE to treat knee osteoarthritis (OA) pain. DUROLANE, is a single-injection hyaluronic acid (HA)-based joint-fluid treatment for patients. DUROLANE will be one of two single-injection HA products under contract.
OA involves the breakdown, or degeneration, of cartilage and the synovial fluid that cushions and lubricates joint tissues. Injection treatments of HA-based products, such as DUROLANE, help manage knee OA pain.

“We are pleased DUROLANE is among the preferred options available to both Aetna™ Medicare Advantage members and physicians,” said Anthony Doyle, General Manager, Pain Treatments and Restorative Therapies for Bioventus. “Both now have access to a safe HA product that is proven to provide relief from knee OA pain.”

About Bioventus

Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com, and follow the Company on LinkedIn and Twitter. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.

TheFinalCD

TheFinalCD 11 월 전

$BVS - Bioventus GAAP EPS of -$0.07 beats by $0.18, revenue of $129.45M beats by $11.07M https://t.co/IGk1Zy2r5X— Seeking Alpha Market Currents (@MarketCurrents) May 7, 2024

Monksdream

Monksdream 11 월 전

PIMCO Intermediate Munic...

Procure Space ETF

Direxion Daily Travel & ...

Schwab Fundamental US Br...

Hashdex Ethereum

Constellation Energy

AEX X5 Leverage Net Return

iShares 1 to 3 Year Trea...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관